Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05441852 · ClinicalTrials.gov registry record
A Study to Detect Hyperkalemia Using Smartphone-enabled Electrocardiogram (EKG)
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 1,151
- Enrollment target
NCT05441852: Completed study, sponsored by Mayo Clinic.
NCT05441852 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 1,151 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05441852 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 1,151 participants
- Enrollment target
Study Summary
The purpose of this study is to validate the real-world performance of a previously developed Artificial Intelligence - Electrocardiogram (AI-ECG) algorithm for identification of hyperkalemia with a six-lead mobile-enhanced device .
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,151 participants |
| Start Date | 2022-03-31 |
| Est. Completion | 2023-07-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05441852
The ClinicalTrials.gov registry entry for NCT05441852 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05441852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05441852 about?
NCT05441852 is a clinical study titled "A Study to Detect Hyperkalemia Using Smartphone-enabled Electrocardiogram (EKG)". The purpose of this study is to validate the real-world performance of a previously developed Artificial Intelligence - Electrocardiogram (AI-ECG) algorithm for identification of hyperkalemia with a six-lead mobile-enhanced device .
What is the current status of trial NCT05441852?
This trial is currently completed. The enrollment target is 1,151 participants. The study started on 2022-03-31. Estimated completion is 2023-07-07.
Who is sponsoring clinical trial NCT05441852?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.